The market has been red hot, and momentum investors have been lined up to take advantage. But, with two fresh vaccine solutions already in the mix and the Fed and Treasury cutting checks for the economy at an all-time record pace, the real upward potential for speculative stocks in this market is difficult to gauge. So far, this year, there have been 88 IPO’s for net negative income new issues, at a ratio that’s twice the pace we saw in the mid to late 1990’s. After that point, two decades...

read more